How are you taking part in this consultation?

You will not be able to change how you comment later.

You must be signed in to answer questions

  • Question on Consultation

    Are there any issues that require special attention in light of NICE’s duties to have due regard to the need to eliminate unlawful discrimination and promote equality and foster good relations between people with a characteristic protected by the equalities legislation and others?
The content on this page is not current guidance and is only for the purposes of the consultation process.

Pressurised intraperitoneal aerosol chemotherapy for peritoneal carcinomatosis

Closed for comments This consultation ended on at   Request commenting lead permission

Introduction

Peritoneal carcinomatosis is cancer that has spread inside the peritoneal cavity (the space between the 2 membranes that separate the organs in the abdomen from the abdominal wall). It can happen with cancers in the pelvis, such as ovarian cancer, or in the abdomen, such as bowel cancer, and occasionally with cancers elsewhere in the body. In this procedure, chemotherapy is sprayed inside the peritoneal cavity through a small tube inserted into the abdomen for several minutes. The aim is to apply the chemotherapy directly to the cancer.

NICE is looking at pressurised intraperitoneal aerosol chemotherapy for peritoneal carcinomatosis.

NICE's interventional procedures advisory committee met to consider the evidence and the opinions of specialist advisers, who are consultants with knowledge of the procedure.

This document contains the draft guidance for consultation. Your views are welcome, particularly:

  • comments on the draft recommendations

  • information about factual inaccuracies

  • additional relevant evidence, with references if possible.

NICE is committed to promoting equality of opportunity, eliminating unlawful discrimination and fostering good relations between people with particular protected characteristics and others.

This is not NICE's final guidance on this procedure. The draft guidance may change after this consultation.

After consultation ends, the committee will:

  • meet again to consider the consultation comments, review the evidence and make appropriate changes to the draft guidance

  • prepare a second draft, which will go through a resolution process before the final guidance is agreed.

Please note that we reserve the right to summarise and edit comments received during consultation or not to publish them at all if, in the reasonable opinion of NICE, there are a lot of comments or if publishing the comments would be unlawful or otherwise inappropriate.

Closing date for comments: 22 August 2019

Target date for publication of guidance: November 2019